(Q81999267)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802705%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Targeting the CD134-CD134L interaction using anti-CD134 and/or rhCD134 fusion protein as a possible strategy to prevent lupus nephritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802705%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802705%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Yan-bin Zhou

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802705%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Ren-gao Ye

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802705%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

You-ji Li

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802705%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

20 September 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802705%20AND%20SRC:MED&resulttype=core&format=json

Rheumatology International

14 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802705%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802705%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802705%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

417-425

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18802705%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00296-008-0697-2

14 January 2020

exact match

0 references

cites work

Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus

1 reference

12 December 2020

OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors

1 reference

12 December 2020

Inactive systemic lupus erythematosus id associated with a normal stimulated Th(1)/Th(2) cytokine secretory pattern

1 reference

12 December 2020

Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses

1 reference

12 December 2020

OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells

1 reference

12 December 2020

Intrarenal cytokine gene expression in lupus nephritis

1 reference

12 December 2020

Effect of antibody to CD134 on perforin-mediated cytolysis in human peripheral blood mononuclear cells.

1 reference

12 December 2020

Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2

1 reference

12 December 2020

The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement

1 reference

12 December 2020

OX40: targeted immunotherapy--implications for tempering autoimmunity and enhancing vaccines

1 reference

12 December 2020

Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines.

1 reference

12 December 2020

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

1 reference

12 December 2020

Th1/Th2 balance of SLE patients with lupus nephritis.

1 reference

12 December 2020

In vitro and in vivo activities of OX40 (CD134)-IgG fusion protein isoforms with different levels of immune-effector functions

1 reference

12 December 2020

Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines

1 reference

12 December 2020

Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis

1 reference

12 December 2020

CD80 and CD86 costimulatory molecules regulate crescentic glomerulonephritis by different mechanisms.

1 reference

12 December 2020

The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis.

1 reference

12 December 2020

The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo

1 reference

12 December 2020

Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells.

1 reference

12 December 2020

Regulation of T-cell migration and effector functions: insights from in vivo imaging studies

1 reference

12 December 2020

Engagement of the OX-40 receptor in vivo enhances antitumor immunity

1 reference

12 December 2020

Development and characterization of recombinant human Fc:OX40L fusion protein linked via a coiled-coil trimerization domain

1 reference

12 December 2020

TNF/TNFR family members in costimulation of T cell responses

1 reference

12 December 2020

Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion

1 reference

12 December 2020

CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus

1 reference

12 December 2020

Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis

1 reference

12 December 2020

Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein

1 reference

12 December 2020

OX40 (CD134) blockade inhibits the co-stimulatory cascade and promotes heart allograft survival.

1 reference

12 December 2020

Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis

1 reference

12 December 2020

Cytokine expression in lupus kidneys

1 reference

12 December 2020

Therapeutic effect of anti-OX40L and anti-TNF-alpha MAbs in a murine model of chronic colitis

1 reference

12 December 2020

Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients

1 reference

12 December 2020

4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB

1 reference

12 December 2020

Anti-OX40 (CD134) administration to nonhuman primates: immunostimulatory effects and toxicokinetic study

1 reference

12 December 2020